Growth Metrics

Catheter Precision (VTAK) Amortization - Goodwill (2023)

Catheter Precision (VTAK) reported Amortization - Goodwill of -$34000.0 for Q4 2023, down 100.7% on a QoQ basis from $4.8 million in Q2 2023.

Catheter Precision (VTAK) has 1 years of Amortization - Goodwill data on file, last reported at -$34000.0 in Q4 2023.

  • Quarterly Amortization - Goodwill changed N/A year-over-year to -$34000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$34000.0 (down 100.06% YoY) and the FY2023 annual result came in at $60.9 million, changed N/A from the prior year.
  • Amortization - Goodwill fell to -$34000.0 in Q4 2023 per VTAK's latest filing, from $4.8 million in the prior quarter.
  • Across five years, Amortization - Goodwill topped out at $56.1 million in Q1 2023 and bottomed at -$34000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Catheter Precision 2.01 Mn 1.20 Mn 390,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -34,000.00
Jun 30, 2023 4.85 Mn
Mar 31, 2023 56.09 Mn